170 related articles for article (PubMed ID: 38562854)
21. Characterization of cannabinoid receptors expressed in Ewing sarcoma TC-71 and A-673 cells as potential targets for anti-cancer drug development.
Shoeib AM; Yarbrough AL; Ford BM; Franks LN; Urbaniak A; Hensley LL; Benson LN; Mu S; Radominska-Pandya A; Prather PL
Life Sci; 2021 Nov; 285():119993. PubMed ID: 34592231
[TBL] [Abstract][Full Text] [Related]
22. Ligand-Assisted Protein Structure (LAPS): An Experimental Paradigm for Characterizing Cannabinoid-Receptor Ligand-Binding Domains.
Janero DR; Korde A; Makriyannis A
Methods Enzymol; 2017; 593():217-235. PubMed ID: 28750804
[TBL] [Abstract][Full Text] [Related]
23. Cannabinoid receptor-interacting protein 1a modulates CB1 receptor signaling and regulation.
Smith TH; Blume LC; Straiker A; Cox JO; David BG; McVoy JR; Sayers KW; Poklis JL; Abdullah RA; Egertová M; Chen CK; Mackie K; Elphick MR; Howlett AC; Selley DE
Mol Pharmacol; 2015 Apr; 87(4):747-65. PubMed ID: 25657338
[TBL] [Abstract][Full Text] [Related]
24. Identification of BiP as a CB
Costas-Insua C; Moreno E; Maroto IB; Ruiz-Calvo A; Bajo-Grañeras R; Martín-Gutiérrez D; Diez-Alarcia R; Vilaró MT; Cortés R; García-Font N; Martín R; Espina M; Botta J; Ginés S; McCormick PJ; Sánchez-Prieto J; Galve-Roperh I; Mengod G; Urigüen L; Marsicano G; Bellocchio L; Canela EI; Casadó V; Rodríguez-Crespo I; Guzmán M
J Neurosci; 2021 Sep; 41(38):7924-7941. PubMed ID: 34353897
[TBL] [Abstract][Full Text] [Related]
25. Cannabinoid receptor interacting protein (CRIP1a) attenuates CB1R signaling in neuronal cells.
Blume LC; Eldeeb K; Bass CE; Selley DE; Howlett AC
Cell Signal; 2015 Mar; 27(3):716-726. PubMed ID: 25446256
[TBL] [Abstract][Full Text] [Related]
26. The influence of beta-arrestin2 on cannabinoid CB1 receptor coupling to G-proteins and subcellular localization and relative levels of beta-arrestin1 and 2 in mouse brain.
Breivogel CS; Puri V; Lambert JM; Hill DK; Huffman JW; Razdan RK
J Recept Signal Transduct Res; 2013 Dec; 33(6):367-79. PubMed ID: 24094141
[TBL] [Abstract][Full Text] [Related]
27. Biased Type 1 Cannabinoid Receptor Signaling Influences Neuronal Viability in a Cell Culture Model of Huntington Disease.
Laprairie RB; Bagher AM; Kelly ME; Denovan-Wright EM
Mol Pharmacol; 2016 Mar; 89(3):364-75. PubMed ID: 26700564
[TBL] [Abstract][Full Text] [Related]
28. The proximal and distal C-terminal tail domains of the CB1 cannabinoid receptor mediate G protein coupling.
Nie J; Lewis DL
Neuroscience; 2001; 107(1):161-7. PubMed ID: 11744255
[TBL] [Abstract][Full Text] [Related]
29. Subsynaptic Distribution, Lipid Raft Targeting and G Protein-Dependent Signalling of the Type 1 Cannabinoid Receptor in Synaptosomes from the Mouse Hippocampus and Frontal Cortex.
Saumell-Esnaola M; Barrondo S; García Del Caño G; Goicolea MA; Sallés J; Lutz B; Monory K
Molecules; 2021 Nov; 26(22):. PubMed ID: 34833992
[TBL] [Abstract][Full Text] [Related]
30. Regulation of CB1 cannabinoid receptor trafficking by the adaptor protein AP-3.
Rozenfeld R; Devi LA
FASEB J; 2008 Jul; 22(7):2311-22. PubMed ID: 18267983
[TBL] [Abstract][Full Text] [Related]
31. Constitutive endocytic cycle of the CB1 cannabinoid receptor.
Leterrier C; Bonnard D; Carrel D; Rossier J; Lenkei Z
J Biol Chem; 2004 Aug; 279(34):36013-21. PubMed ID: 15210689
[TBL] [Abstract][Full Text] [Related]
32. Dynamic imaging of cannabinoid receptor 1 vesicular trafficking in cultured astrocytes.
Osborne KD; Lee W; Malarkey EB; Irving AJ; Parpura V
ASN Neuro; 2009 Dec; 1(5):. PubMed ID: 19906012
[TBL] [Abstract][Full Text] [Related]
33. Design and validation of recombinant protein standards for quantitative Western blot analysis of cannabinoid CB
Saumell-Esnaola M; Elejaga-Jimeno A; Echeazarra L; Borrega-Román L; Barrondo S; López de Jesús M; González-Burguera I; Gómez-Caballero A; Goicolea MA; Sallés J; García Del Caño G
Microb Cell Fact; 2022 Sep; 21(1):192. PubMed ID: 36109736
[TBL] [Abstract][Full Text] [Related]
34. Dual intracellular signaling pathways mediated by the human cannabinoid CB1 receptor.
Calandra B; Portier M; Kernéis A; Delpech M; Carillon C; Le Fur G; Ferrara P; Shire D
Eur J Pharmacol; 1999 Jun; 374(3):445-55. PubMed ID: 10422789
[TBL] [Abstract][Full Text] [Related]
35. Structural Insights into CB1 Receptor Biased Signaling.
Al-Zoubi R; Morales P; Reggio PH
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31013934
[TBL] [Abstract][Full Text] [Related]
36. Bidirectional allosteric interactions between cannabinoid receptor 1 (CB
Bagher AM; Laprairie RB; Toguri JT; Kelly MEM; Denovan-Wright EM
Eur J Pharmacol; 2017 Oct; 813():66-83. PubMed ID: 28734930
[TBL] [Abstract][Full Text] [Related]
37. Dysregulation of cannabinoid CB1 receptor and associated signaling networks in brains of cocaine addicts and cocaine-treated rodents.
Álvaro-Bartolomé M; García-Sevilla JA
Neuroscience; 2013 Sep; 247():294-308. PubMed ID: 23727505
[TBL] [Abstract][Full Text] [Related]
38. Functional Selectivity of Cannabinoid Type 1 G Protein-Coupled Receptor Agonists in Transactivating Glycosylated Receptors on Cancer Cells to Induce Epithelial-Mesenchymal Transition Metastatic Phenotype.
Bunsick DA; Matsukubo J; Aldbai R; Baghaie L; Szewczuk MR
Cells; 2024 Mar; 13(6):. PubMed ID: 38534324
[TBL] [Abstract][Full Text] [Related]
39. Voltage dependence of the cannabinoid CB1 receptor.
Goldberger E; Tauber M; Ben-Chaim Y
Front Pharmacol; 2022; 13():1022275. PubMed ID: 36304142
[TBL] [Abstract][Full Text] [Related]
40. Membrane assembly of the cannabinoid receptor 1: impact of a long N-terminal tail.
Andersson H; D'Antona AM; Kendall DA; Von Heijne G; Chin CN
Mol Pharmacol; 2003 Sep; 64(3):570-7. PubMed ID: 12920192
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
